Reply To: Covid 19 Vaccine

Pfizer and BioNTech announced Today they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States. They will be recommending the booster shot about 9 months after the initial 2 shots, then annually.

The booster is being tested in their clinical trial and I hope we hear about results soon.